Literature DB >> 1846016

Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy.

M L Zeneroli1, M Baraldi, E Ventura, C Vezzelli, O Tofanetti, M Germini, I Casciarri.   

Abstract

The binding characteristics of gamma-aminobutyric acid-A (GABA-A) receptors and the kinetic characteristics of the target enzyme of GABA synthesis in nerve terminals, glutamic acid decarboxylase (GAD), were studied in a dog model of portal-systemic encephalopathy obtained by porta-caval shunt performed in dimethylnitrosamine pretreated animals. Furthermore the properties of dopamine receptors and the levels of catecholamines of encephalopathic dogs were investigated. The mild stage of encephalopathy was characterized by an up-regulation of the inhibitory GABA-A receptors probably related to a decrese of GABA in nerve terminals since GAD was decreased and by a slight decrease of catecholamines and by an increased synthesis of octopamine associated with a decreased affinity of dopamine receptors. In the severe stage there was a selection of high affinity GABA-A receptors with an increased number of benzodiazepine recognition sites which were supersensitive to GABA stimulation, a decreased number of Dopamine D-2 receptors and a marked reduction of catecholamines. These data seem to suggest that the neurological disturbances of experimental portal-systemic encephalopathy might be the result of an imbalance between inhibitory and excitatory systems leading to a prevalence of the first one.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846016     DOI: 10.1016/0024-3205(91)90423-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy.

Authors:  U Wysmyk; S S Oja; P Saransaari; J Albrecht
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

2.  Augmented sensitivity to benzodiazepine in septic shock rats.

Authors:  T Komatsubara; Y Kadoi; S Saito
Journal:  Can J Anaesth       Date:  1995-10       Impact factor: 5.063

3.  Release of [3H]dopamine from striatal and cerebral cortical slices from rats with thioacetamide-induced hepatic encephalopathy: different responses to stimulation by potassium ions and agonists of ionotropic glutamate receptors.

Authors:  H D Borkowska; S S Oja; P Saransaari; J Albrecht
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

Review 4.  The role of inhibitory amino acidergic neurotransmission in hepatic encephalopathy: a critical overview.

Authors:  Jan Albrecht; Magdalena Zielińska
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

5.  Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.

Authors:  Mohammad Nasehi; Samaneh Amin Yavari; Mohammad Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2013-02-13       Impact factor: 4.530

Review 6.  Cholestasis and behavioral disorders.

Authors:  Delaram Eslimi Esfahani; Mohammad Reza Zarrindast
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.